title: [Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
authors.affiliation: Departamento de Pediatría, Hospital Clínico y Provincial de Barcelona.
authors.forename: E
authors.initials: E
authors.lastname: de la Cruz Amorós
authors.forename: N
authors.initials: N
authors.lastname: Lambruschini Ferri
authors.forename: J M
authors.initials: JM
authors.lastname: Rodríguez Miguélez
authors.forename: J M
authors.initials: JM
authors.lastname: Torres Simón
mesh_terms: D000493:Allopurinol / Q000627:therapeutic use*; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007159:Immunologic Tests; D007223:Infant; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use*; D013012:Sorbitol / Q000031:analogs & derivatives*
chemical_list: D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009942:Organometallic Compounds; D013012:Sorbitol; D000493:Allopurinol; D008536:Meglumine; D000077485:Meglumine Antimoniate
vernacular_title: Glucantime y alopurinol en el tratamiento de la leishmaniosis visceral infantil persistente.